Literature DB >> 18179881

Biallelic mutation of BEST1 causes a distinct retinopathy in humans.

Rosemary Burgess1, Ian D Millar, Bart P Leroy, Jill E Urquhart, Ian M Fearon, Elfrida De Baere, Peter D Brown, Anthony G Robson, Genevieve A Wright, Philippe Kestelyn, Graham E Holder, Andrew R Webster, Forbes D C Manson, Graeme C M Black.   

Abstract

We describe a distinct retinal disorder, autosomal-recessive bestrophinopathy (ARB), that is consequent upon biallelic mutation in BEST1 and is associated with central visual loss, a characteristic retinopathy, an absent electro-oculogram light rise, and a reduced electroretinogram. Heterozygous mutations in BEST1 have previously been found to cause the two dominantly inherited disorders, Best macular dystrophy and autosomal-dominant vitreoretinochoroidopathy. The transmembrane protein bestrophin-1, encoded by BEST1, is located at the basolateral membrane of the retinal pigment epithelium in which it probably functions as a Cl(-) channel. We sequenced BEST1 in five families, identifying DNA variants in each of ten alleles. These encoded six different missense variants and one nonsense variant. The alleles segregated appropriately for a recessive disorder in each family. No clinical or electrophysiological abnormalities were identified in any heterozygotes. We conducted whole-cell patch-clamping of HEK293 cells transfected with bestrophin-1 to measure the Cl(-) current. Two ARB missense isoforms severely reduced channel activity. However, unlike two other alleles previously associated with Best disease, cotransfection with wild-type bestrophin-1 did not impair the formation of active wild-type bestrophin-1 channels, consistent with the recessive nature of the condition. We propose that ARB is the null phenotype of bestrophin-1 in humans.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18179881      PMCID: PMC2253971          DOI: 10.1016/j.ajhg.2007.08.004

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  29 in total

1.  O2 sensing by recombinant TWIK-related halothane-inhibitable K+ channel-1 background K+ channels heterologously expressed in human embryonic kidney cells.

Authors:  V A Campanucci; S T Brown; K Hudasek; I M O'kelly; C A Nurse; I M Fearon
Journal:  Neuroscience       Date:  2005-09-08       Impact factor: 3.590

2.  Insertion and topology of normal and mutant bestrophin-1 in the endoplasmic reticulum membrane.

Authors:  Vladimir M Milenkovic; Andrea Rivera; Franziska Horling; Bernhard H F Weber
Journal:  J Biol Chem       Date:  2006-11-15       Impact factor: 5.157

3.  Variant phenotype of Best vitelliform macular dystrophy associated with compound heterozygous mutations in VMD2.

Authors:  Patrik Schatz; Joakim Klar; Sten Andréasson; Vesna Ponjavic; Niklas Dahl
Journal:  Ophthalmic Genet       Date:  2006-06       Impact factor: 1.803

4.  Late development of vitelliform lesions and flecks in a patient with best disease: clinicopathologic correlation.

Authors:  Robert F Mullins; Kean T Oh; Edward Heffron; Gregory S Hageman; Edwin M Stone
Journal:  Arch Ophthalmol       Date:  2005-11

5.  Hydrodynamic properties of porcine bestrophin-1 in Triton X-100.

Authors:  J Brett Stanton; Andrew F X Goldberg; George Hoppe; Lihua Y Marmorstein; Alan D Marmorstein
Journal:  Biochim Biophys Acta       Date:  2006-03-06

6.  Molecular testing for hereditary retinal disease as part of clinical care.

Authors:  Katy Downs; David N Zacks; Rafael Caruso; Athanasios J Karoukis; Kari Branham; Beverly M Yashar; Mark H Haimann; Karmen Trzupek; Meira Meltzer; Delphine Blain; Julia E Richards; Richard G Weleber; John R Heckenlively; Paul A Sieving; Radha Ayyagari
Journal:  Arch Ophthalmol       Date:  2007-02

7.  Genotype-phenotype correlation and longitudinal course in ten families with Best vitelliform macular dystrophy.

Authors:  B Wabbels; M N Preising; U Kretschmann; A Demmler; B Lorenz
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2006-04-13       Impact factor: 3.117

8.  New VMD2 gene mutations identified in patients affected by Best vitelliform macular dystrophy.

Authors:  D Marchant; K Yu; K Bigot; O Roche; A Germain; D Bonneau; V Drouin-Garraud; D F Schorderet; F Munier; D Schmidt; P Le Neindre; C Marsac; M Menasche; J L Dufier; R Fischmeister; C Hartzell; M Abitbol
Journal:  J Med Genet       Date:  2007-02-07       Impact factor: 6.318

9.  Bestrophin gene mutations cause canine multifocal retinopathy: a novel animal model for best disease.

Authors:  Karina E Guziewicz; Barbara Zangerl; Sarah J Lindauer; Robert F Mullins; Lynne S Sandmeyer; Bruce H Grahn; Edwin M Stone; Gregory M Acland; Gustavo D Aguirre
Journal:  Invest Ophthalmol Vis Sci       Date:  2007-05       Impact factor: 4.799

10.  The light peak of the electroretinogram is dependent on voltage-gated calcium channels and antagonized by bestrophin (best-1).

Authors:  Lihua Y Marmorstein; Jiang Wu; Precious McLaughlin; John Yocom; Mike O Karl; Rudgar Neussert; Soenke Wimmers; J Brett Stanton; Ronald G Gregg; Olaf Strauss; Neal S Peachey; Alan D Marmorstein
Journal:  J Gen Physiol       Date:  2006-05       Impact factor: 4.086

View more
  111 in total

1.  SOX9, through interaction with microphthalmia-associated transcription factor (MITF) and OTX2, regulates BEST1 expression in the retinal pigment epithelium.

Authors:  Tomohiro Masuda; Noriko Esumi
Journal:  J Biol Chem       Date:  2010-06-08       Impact factor: 5.157

2.  Clinical utility gene card for: BEST1-related dystrophies (Bestrophinopathies).

Authors:  Simon C Ramsden; Alice E Davidson; Bart P Leroy; Anthony T Moore; Andrew R Webster; Graeme C M Black; Forbes D C Manson
Journal:  Eur J Hum Genet       Date:  2012-01-11       Impact factor: 4.246

Review 3.  Bestrophins and retinopathies.

Authors:  Qinghuan Xiao; H Criss Hartzell; Kuai Yu
Journal:  Pflugers Arch       Date:  2010-03-28       Impact factor: 3.657

Review 4.  The retinal pigment epithelium in health and disease.

Authors:  J R Sparrow; D Hicks; C P Hamel
Journal:  Curr Mol Med       Date:  2010-12       Impact factor: 2.222

5.  BEST1-related autosomal dominant vitreoretinochoroidopathy: a degenerative disease with a range of developmental ocular anomalies.

Authors:  A Vincent; C McAlister; C Vandenhoven; E Héon
Journal:  Eye (Lond)       Date:  2010-11-12       Impact factor: 3.775

Review 6.  Genetic characterization and disease mechanism of retinitis pigmentosa; current scenario.

Authors:  Muhammad Umar Ali; Muhammad Saif Ur Rahman; Jiang Cao; Ping Xi Yuan
Journal:  3 Biotech       Date:  2017-07-18       Impact factor: 2.406

Review 7.  BEST1: the Best Target for Gene and Cell Therapies.

Authors:  Tingting Yang; Sally Justus; Yao Li; Stephen H Tsang
Journal:  Mol Ther       Date:  2015-09-21       Impact factor: 11.454

Review 8.  Autophagy in the eye: implications for ocular cell health.

Authors:  Laura S Frost; Claire H Mitchell; Kathleen Boesze-Battaglia
Journal:  Exp Eye Res       Date:  2014-05-06       Impact factor: 3.467

9.  Rescue of volume-regulated anion current by bestrophin mutants with altered charge selectivity.

Authors:  Li-Ting Chien; H Criss Hartzell
Journal:  J Gen Physiol       Date:  2008-11       Impact factor: 4.086

10.  Suppression of Ca2+ signaling in a mouse model of Best disease.

Authors:  Youwen Zhang; J Brett Stanton; Jiang Wu; Kuai Yu; H Criss Hartzell; Neal S Peachey; Lihua Y Marmorstein; Alan D Marmorstein
Journal:  Hum Mol Genet       Date:  2010-01-06       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.